Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | 36,000 | reported | 26 Jun 2025 | tx 8+158,570 |
| IDERA PHARMACEUTICALS, INC. | 26,000 | reported | 23 Jun 2022 | tx 28+1,414,075 |
| Voyager Therapeutics, Inc. | 24,000 | reported | 03 Jun 2025 | tx 12+188,000 |
| GTC BIOTHERAPEUTICS INC | 19,025 | reported | 31 Dec 2009 | tx 21+136,718 |
| GENZYME CORP | 9,750 | reported | 04 Apr 2011 | tx 30+104,875−319,035 |
| Orchard Therapeutics plc | 0 | reported | 24 Jan 2024 | tx 7+226,000−195,391 |
| PALVELLA THERAPEUTICS, INC. | 0 | reported | 12 Dec 2024 | tx 13+342,501−1 |
| COLUMBIA LABORATORIES INC | 0 | reported | 14 Aug 2018 | tx 17+196,341−180,747 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jun 2025 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 36,000 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | Voyager Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 12 Dec 2024 | OTHER | PALVELLA THERAPEUTICS, INC. | 1 | 0.01 USD | |
| 07 Aug 2024 | PURCHASE | PALVELLA THERAPEUTICS, INC. | 1 | 1.00 USD | first after silenceanomaly |
| 17 Jun 2024 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Voyager Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 44,391 | — | |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 46,000 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 105,000 | 0.00 USD | deriv |
| 27 Jun 2023 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 45,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Orchard Therapeutics plc | 105,000 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Voyager Therapeutics, Inc. | 22,000 | 0.00 USD | deriv |
| 27 Jun 2022 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 23 Jun 2022 | GRANT_AWARD | IDERA PHARMACEUTICALS, INC. | 26,000 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 45,000 | 0.00 USD | deriv |
| 06 Jun 2022 | GRANT_AWARD | Voyager Therapeutics, Inc. | 22,000 | 0.00 USD | deriv |
| 07 Jun 2022 | GRANT_AWARD | Orchard Therapeutics plc | 46,000 | 0.00 USD | deriv |
| 28 Jun 2021 | PURCHASE | Fulcrum Therapeutics, Inc. | 10,000 | 9.16 USD | first after silence |
| 25 Jun 2021 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 45,000 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Orchard Therapeutics plc | 40,000 | 0.00 USD | deriv |
| 09 Jun 2021 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 08 Jun 2021 | GRANT_AWARD | IDERA PHARMACEUTICALS, INC. | 26,000 | 0.00 USD | deriv |
| 03 Jun 2021 | GRANT_AWARD | Voyager Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | IDERA PHARMACEUTICALS, INC. | 14,773 | 1.32 USD |
5 purchases reported after at least 12 months of silence — most recent on 07 Aug 2024.